Overview
House Rx has raised $55 million in Series B funding, led by New Enterprise Associates and Town Hall Ventures, to expand its AI-driven in-clinic specialty pharmacy model. This funding increases total investment to $100 million, addressing the need for enhanced pharmacy management across various medical specialties.
Products
Loading...
Recent Deals
Investors: New Enterprise Associates, Town Hall Ventures
House Rx has raised $55 million in Series B funding, led by New Enterprise Associates and Town Hall Ventures, to expand its AI-driven in-clinic specialty pharmacy model. This funding increases total investment to $100 million, addressing the need for enhanced pharmacy management across various medical specialties.